Kolumne, ORE

Original-Research: S Immo AG - von NuWays AG Einstufung von NuWays AG zu S Immo AG Unternehmen: S Immo AG ISIN: AT0000652250 Anlass der Studie: Q3 Review Empfehlung: BUY seit: 30.11.2023 Kursziel: EUR 17,00 Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: Analyst: Philipp Sennewald Strong Q3 and another acquisition; chg.

30.11.2023 - 09:02:41

Original-Research: S Immo AG (von NuWays AG): BUY


Original-Research: S Immo AG - von NuWays AG

Einstufung von NuWays AG zu S Immo AG

Unternehmen: S Immo AG
ISIN: AT0000652250

Anlass der Studie: Q3 Review
Empfehlung: BUY
seit: 30.11.2023
Kursziel: EUR 17,00
Kursziel auf Sicht von: 12 Monaten
Letzte Ratingänderung: 
Analyst: Philipp Sennewald

Strong Q3 and another acquisition; chg.
 
Yesterday, S IMMO released a strong set of Q3 results, showing continued
top-line growth as well as significantly improved operating profitability.
Moreover, the company announced the acquisition of another portfolio in the
CEE region.
 
Q3 total revenues increased 24% yoy to EUR 81.1m (eNuW: EUR 79.8m) which was
mainly driven by last year's acquisitions in the CEE region, resulting in a
rental income increase of 24% yoy to EUR 49.0m (eNuW: EUR 47.5m). Notably, Q3
revenues from hotel operations continued to recover post Covid, as segment
sales increased 26% yoy to EUR 18.5m (eNuW: EUR 19.0m) while the segment's
operating margin significantly improved by 8.9pp yoy to 29.9%.
 
Against this backdrop, FFO was up 34% yoy to EUR 25.1m, which was however
below our estimate of EUR 28.3m. The gap is mainly explained by negative FX
effects to the tune of EUR 2.9m. The still overproportionate FFO increase is
based on reduced property operating as well as SG&A expenses.
 
While the operating business remains on a strong level, the company
provided further positive newsflow with another major CEE acquisition. As
flagged in our recent preview note, the company signed an LOI for a Czech
portfolio. Meanwhile, the deal for the 11 properties, which comprise a
lettable area of 138k sqm, has been signed. The portfolio is currently
valued at EUR 481m an generated rental income of c. EUR 29m. With this, S IMMO
acquired properties with a total annual rental income of c. EUR 50m YTD.
 
The new acquisitions are seen to be mainly financed with the proceeds from
the current disposal program in Germany. While properties worth EUR 621m have
already been sold, EUR 400m are still in the disposal pipeline (eNuW: EUR 250m
of which in Germany). As a quick reminder, yields in CEE are on average
3-4pp higher compared to German residential. Hence, the rebalancing of the
portfolio (e.g. selling German properties & buying CEE properties) should
substantially increase annual rental income, thus creating significant
shareholder value.
 
We confirm our BUY recommendation with an unchanged PT of EUR 17.00 based on
NTA and DDM.

Die vollständige Analyse können Sie hier downloaden:
http://www.more-ir.de/d/28431.pdf
Die Analyse oder weiterführende Informationen zu dieser können Sie hier downloaden
www.nuways-ag.com/research.

Kontakt für Rückfragen
NuWays AG  - Equity Research
Web: www.nuways-ag.com
Email: research@nuways-ag.com
LinkedIn: https://www.linkedin.com/company/nuwaysag
Adresse: Mittelweg 16-17, 20148 Hamburg, Germany
++++++++++
Diese Meldung ist keine Anlageberatung oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.
Offenlegung möglicher Interessenskonflikte nach § 85 WpHG beim oben analysierten Unternehmen befinden sich in der vollständigen Analyse.
++++++++++

-------------------übermittelt durch die EQS Group AG.-------------------


Für den Inhalt der Mitteilung bzw. Research ist alleine der Herausgeber bzw. 
Ersteller der Studie verantwortlich. Diese Meldung ist keine Anlageberatung
oder Aufforderung zum Abschluss bestimmter Börsengeschäfte.

@ dpa.de

Weitere Meldungen

Original-Research: Schloss Wachenheim AG (von First Berlin Equity Research Gm... Original-Research: Schloss Wachenheim AG - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to Schloss Wachenheim AG Company Name: Schloss Wachenheim AG ISIN: DE0007229007 Reason for the research: Q3 23/24 results Recommendation: Buy from: 13.05.2024 Target price: EUR22,00 Target price on sight of: 12 months Last rating change: - Analyst: Simon Scholes, CFA First Berlin Equity Research has published a research update on Schloss Wachenheim AG (ISIN: DE0007229007). (Boerse, 13.05.2024 - 11:41) weiterlesen...

Original-Research: LION E-Mobility AG (von NuWays AG): Kaufen Original-Research: LION E-Mobility AG - from NuWays AG Classification of NuWays AG to LION E-Mobility AG Company Name: LION E-Mobility AG ISIN: CH0560888270 Reason for the research: Update Recommendation: Kaufen from: 13.05.2024 Target price: EUR 7.00 Target price on sight of: 12 Monaten Last rating change: Analyst: Christian Sandherr CMD underpins promising mid-term prospects; chg Q1 sales came in at a mere EUR 1.2m with an EBITDA of EUR -2.6m. This is a significant decrease compared to the particularly strong Q4 last year with roughly EUR 26m sales and EUR 1m EBITDA. (Boerse, 13.05.2024 - 09:06) weiterlesen...

Original-Research: MLP SE (von NuWays AG): Kaufen Original-Research: MLP SE - from NuWays AG Classification of NuWays AG to MLP SE Company Name: MLP SE ISIN: DE0006569908 Reason for the research: Update Recommendation: Kaufen from: 13.05.2024 Target price: EUR 12.00 Target price on sight of: 12 Monaten Last rating change: Analyst: Henry Wendisch Q1 preview: performance fees and banking to drive EBIT Topic: MLP's Q1 results are due on Wednesday, May 15th and we expect a solid EBIT expansion driven by a contribution of performance fees (first time since Q4'21) as well as continuous support from the banking business. (Boerse, 13.05.2024 - 09:02) weiterlesen...

Original-Research: Multitude SE (von NuWays AG): Kaufen Original-Research: Multitude SE - from NuWays AG Classification of NuWays AG to Multitude SE Company Name: Multitude SE ISIN: FI4000106299 Reason for the research: Update Recommendation: Kaufen from: 13.05.2024 Last rating change: Analyst: Frederik Jarchow Solid Q1 figures ahead // Multitude to continue on growth path On Thursday, Multitude will report Q1Ž24 figures that should come in solid, but with room for sequential improvements until YE. (Boerse, 13.05.2024 - 09:01) weiterlesen...

Original-Research: Nynomic AG (von Montega AG): Kaufen Original-Research: Nynomic AG - von Montega AG Einstufung von Montega AG zu Nynomic AG Unternehmen: Nynomic AG ISIN: DE000A0MSN11 Anlass der Studie: Update Empfehlung: Kaufen seit: 10.05.2024 Kursziel: 47,00 EUR (zuvor: 48,00 EUR) Kursziel auf Sicht von: 12 Monaten Letzte Ratingänderung: - Analyst: Miguel Lago Mascato Q1: Solider Jahresauftakt - Steigerung der ausgezeichneten H2/23-Performance & M&A-Newsflow erwartet Nynomic hat Mittwoch Q1-Zahlen veröffentlicht, die eine spürbare Steigerung ggü. (Boerse, 10.05.2024 - 16:16) weiterlesen...

Original-Research: MPH Health Care AG (von First Berlin Equity Research GmbH)... Original-Research: MPH Health Care AG - from First Berlin Equity Research GmbH Classification of First Berlin Equity Research GmbH to MPH Health Care AG Company Name: MPH Health Care AG ISIN: DE000A289V03 Reason for the research: Vorläufige Ergebnisse 2023 Recommendation: Kaufen from: 10.05.2024 Target price: EUR81 Target price on sight of: 12 Monate Last rating change: - Analyst: Ellis Acklin First Berlin Equity Research hat ein Research Update zu MPH Health Care AG (ISIN: DE000A289V03) veröffentlicht. (Boerse, 10.05.2024 - 12:41) weiterlesen...